Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
52.65 (1y: +19%)
Market Cap 140.9 B P/E(ttm) 20.50
Enterprise Value 164.44 B P/B 16.30
GSK- NYSE (USA)
GlaxoSmithKline PLC
  • Currently 2/5
Business Predictability Rank: 2-Star (On Watch)
Back Testing Results:
Average gain of all 2-Star stocks: 6% per year.
% of Stocks that are in still loss if held for 10yrs: 16%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$52.65
Switch to:
Jump to: Guru Trade | Guru Ownership | Insider Trade

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M140,904Revenue $M40,403Net Margin (%)17.3Z-Score2.7
Enterprise Value $M164,436EPS $2.7Operating Margin %28.0F-Score5
P/E(ttm))20.5Cash Flow Per Share $4.7Pre-tax Margin (%)25.3Higher ROA y-yY
Price/Book16.310-y EBITDA Growth Rate %9.1Quick Ratio0.8Cash flow > EarningsY
Price/Sales3.35-y EBITDA Growth Rate %1.2Current Ratio1.0Lower Leverage y-yN
Price/Cash Flow9.3y-y EBITDA Growth Rate %-3.8ROA % (ttm)11.0Higher Current Ratio y-yY
Dividend Yield %4.5Insider Buy (3m)0ROE % (ttm)78.6Less Shares Outstanding y-yN
Payout Ratio %88.2Shares Outstanding M2,699ROI % (ttm)25.5Gross Margin Increase y-yN

Gurus Latest Trades with GSK

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL
Select Gurus | Default List of Gurus | All Investors | Mutual Fund Gurus | Hedge Fund Gurus
Number of guru portfolios checked: 51.
Total Records: 48   Page:1 2 3 Next Page
TickerGuruDate Action
 Impactdown Price Range
(Average)* 		Current Price Change from Average Comment Current Shares
GSKJohn Hussman 2013-03-31 Reduce-0.57%$43.47 - $46.91
($44.97)		 $ 52.6517%Reduce -95.51%23,500
GSKVanguard Health Care Fund 2013-03-31 Reduce-0.07%$43.47 - $46.91
($44.97)		 $ 52.6517%Reduce -20.49%2,180,381
GSKJohn Hussman 2012-12-31 Add0.58%$41.9 - $47.45
($44.3)		 $ 52.6519%Add 2584.62%523,500
GSKDodge & Cox 2012-12-31 Add0.18%$41.9 - $47.45
($44.3)		 $ 52.6519%Add 5.08%63,302,825
GSKTweedy Browne 2012-12-31 Add0.03%$41.9 - $47.45
($44.3)		 $ 52.6519%Add 20.16%151,264
GSKJoel Greenblatt 2012-12-31 Reduce-0.09%$41.9 - $47.45
($44.3)		 $ 52.6519%Reduce -32.53%60,720
GSKJoel Greenblatt 2012-09-30 Buy 0.28%$44.25 - $47.23
($46.06)		 $ 52.6514%New holding, 89990 sh.89,990
GSKJean-Marie Eveillard 2012-03-31 Buy 0.06%$43.73 - $46.35
($42.21)		 $ 52.6525%New holding, 322701 sh.322,701
GSKCharles Brandes 2011-12-31 Reduce-0.3%$40.53 - $45.74
($44)		 $ 52.6520%Reduce -20.33%3,035,713
GSKJohn Hussman 2011-09-30 Add$38.84 - $44.91
($42.39)		 $ 52.6524%Add 50%16,500
GSKDavid Dreman 2011-09-30 Sold Out -0.0722%$38.84 - $44.91
($42.39)		 $ 52.6524%Sold Out0
GSKTweedy Browne 2011-09-30 Reduce-0.05%$38.84 - $44.91
($42.39)		 $ 52.6524%Reduce -20.57%148,093
GSKDavid Dreman 2011-06-30 Add0.02%$38.78 - $43.74
($42.02)		 $ 52.6525%Add 43.95%87,932
GSKBruce Berkowitz 2011-06-30 Sold Out -0.05%$38.78 - $43.74
($42.02)		 $ 52.6525%Sold Out0
GSKBruce Berkowitz 2011-03-31 Buy 0.05%$36.33 - $39.86
($38.17)		 $ 52.6538%New holding, 190000 sh.190,000
GSKDavid Dreman 2011-03-31 Add0.01%$36.33 - $39.86
($38.17)		 $ 52.6538%Add 47.39%61,084
GSKMario Gabelli 2011-03-31 Sold Out $36.33 - $39.86
($38.17)		 $ 52.6538%Sold Out0
GSKJoel Greenblatt 2011-03-31 Sold Out $36.33 - $39.86
($38.17)		 $ 52.6538%Sold Out0
GSKJoel Greenblatt 2010-12-31 Buy 0.65%$38.28 - $41.86
($39.85)		 $ 52.6532%New holding, 50826 sh.50,826
GSKJohn Hussman 2010-12-31 Buy 0.01%$38.28 - $41.86
($39.85)		 $ 52.6532%New holding, 11000 sh.11,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.
Total Records: 48   Page:1 2 3 Next Page

GSK is held by these Gurus:

Select Gurus | Default List of Gurus | All Investors | Mutual Fund Gurus | Hedge Fund Gurus
Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
GSK Joel Greenblatt 2013-03-3167,33200.16+10.89%
GSK Jean-Marie Eveillard 2013-03-31341,6010.010.05
GSK Warren Buffett 2013-03-311,510,5000.060.08
GSK Tweedy Browne 2013-03-31151,2640.010.18
GSK Dodge & Cox 2013-03-3162,617,6472.323.6-1.08%
GSK PRIMECAP Management 2013-03-3110,101,8550.370.7-5.02%
GSK Charles Brandes 2013-03-311,995,6320.071.1-7.1%
GSK Vanguard Health Care Fund 2013-03-312,180,3810.080.4-20.49%
GSK John Hussman 2013-03-3123,50000.04-95.51%
Premium Most recent portfolio changes are included for Premium Members only!


GSK: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about GSK:

Quarterly/Annual Reports about GSK:

    News about GSK:

    Articles On GuruFocus.com
    20 Best-Yielding Health Care Stocks - Less Volatile Than the Market Apr 02 2013 
    My 4 Favorite Income Stocks with Biggest Earnings Growth Mar 22 2013 
    10 Best Dividend Paying Drug Manufacturing Stocks Mar 02 2013 
    The Best Yielding Ex-Dividend Stocks for Next Week Feb 17 2013 
    Dodge & Cox Explain Why They Are Overweight in Pharmaceuticals Dec 13 2012 
    Warren Buffett’s Best-Yielding Dividend Stocks Dec 05 2012 
    The Other Healthcare Stocks of Warren Buffett Dec 05 2012 
    Yearly Low: GlaxoSmithKline (GSK) Nov 15 2012 
    The 20 Biggest Healthcare Dividend Payer Oct 02 2012 
    10 Best Yielding Drug Manufacturing Stocks Aug 02 2012 

    More From Our Partners
    Elan in Royalty Deal with THRX - Analyst Blog May 14 2013 - ZACKS

    Add Notes, Comments or Ask Questions

    Comments

    No comment yet
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
    Free 7-day Trial
    FEEDBACK